Cancer is the primary cause of death in economically developed countries and the second
leading cause in developing countries. Colorectal cancer (CRC) is the third most common …

Despite great progress has been made in treatment strategies, colorectal cancer (CRC)
remains the predominant life-threatening malignancy with the feature of high morbidity and …

Among soluble actors that have emerged as druggable factors, the chemokine interleukin-8
(IL-8) has emerged as a possible determinant of response to immunotherapy and targeted …

In the United States, colorectal cancer (CRC) is the third most common cancer diagnosis in
both men and women. Many patients are diagnosed with advanced stage CRC which has a …

Background/Aims Cancer-related activation of cytokine networks are central aspects of
tumor development. The goal of the study was to examine the possibility of plasma cytokines …

Colorectal cancer (CRC) remains a major cause of cancer‑related mortality. Consequently,
new diagnostic and therapeutic approaches are being investigated including the serum …

Alternate colorectal cancer (CRC) screening and surveillance strategies are needed to pre-
select candidates for invasive methods. We compared systemic inflammatory profiles in …

Purpose Interleukin-6 (IL-6) plays an important role in human colorectal cancer (CRC)
development. However, the exact clinical and prognostic significance of IL-6 in CRC is still …

Growing evidence proposes an important role for pro-inflammatory cytokines during tumor
development. Several experimental and clinical studies have linked the pleiotropic cytokine …

Background The prognostic value and diagnostic accuracy of Interleukin-8 (IL-8) in
colorectal cancer have been assessed with several studies, but the conclusions were …